Evidence map›Paper›PMID 33106223›Full record

ArticleeLife2020

Metapopulation ecology links antibiotic resistance, consumption, and patient transfers in a network of hospital wards.

Julie Teresa Shapiro, Gilles Leboucher, Anne-Florence Myard-Dury, Pascale Girardo, Anatole Luzzati, Mélissa Mary, Jean-François Sauzon, Bénédicte Lafay, Olivier Dauwalder, Frédéric Laurent and 6 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Associations Between Candida andMicroorganisms · 2025
    Article
  5. Article
  6. Review
  7. A Perfect Storm: COVID-19 and Antimicrobial Resistance.EMJ. Microbiology & infectious diseases · 2022
    Article
  8. The Canadian journal of hospital pharmacy · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Julie Teresa ShapiroCIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France.ORCID 0000-0002-4539-650X
Gilles LeboucherDépartement de Pharmacie, Hospices Civils de Lyon, Lyon, France.ORCID 0000-0001-7043-9834
Anne-Florence Myard-DuryPôle de Santé Publique, Département d'Information Médicale, Hospices Civils de Lyon, Lyon, France.
Pascale GirardoInstitut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
Anatole LuzzatiInstitut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
Mélissa MaryInstitut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
Jean-François SauzonInstitut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
Bénédicte LafayLaboratoire de Biométrie et Biologie Evolutive, UMR CNRS 5558, University of Lyon, Lyon, France.ORCID 0000-0001-5783-5269
Olivier DauwalderInstitut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.ORCID 0000-0003-1722-1582
Frédéric LaurentCIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France.
Gerard LinaCIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France.
Christian ChidiacService des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France.ORCID 0000-0001-7002-2713
Sandrine Couray-TargePôle de Santé Publique, Département d'Information Médicale, Hospices Civils de Lyon, Lyon, France.
François VandeneschCIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France.
Jean-Pierre FlandroisLaboratoire de Biométrie et Biologie Evolutive, UMR CNRS 5558, University of Lyon, Lyon, France.ORCID 0000-0002-4953-9125
Jean-Philippe RasigadeCIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France.ORCID 0000-0002-8264-0452
Hospices Civils de Lyon · FRUniversité Claude Bernard Lyon 1 · FR

Funding

Fondation Innovations en Infectiologie R18037CCFrench Laboratory of Excellence project ECOFECT ANR-11-LABX-0048
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a global threat. A better understanding of how antibiotic use and between-ward patient transfers (or connectivity) impact population-level AMR in hospital networks can help optimize antibiotic stewardship and infection control strategies. Here, we used a metapopulation framework to explain variations in the incidence of infections caused by seven major bacterial species and their drug-resistant variants in a network of 357 hospital wards. We found that ward-level antibiotic consumption volume had a stronger influence on the incidence of the more resistant pathogens, while connectivity had the most influence on hospital-endemic species and carbapenem-resistant pathogens. Piperacillin-tazobactam consumption was the strongest predictor of the cumulative incidence of infections resistant to empirical sepsis therapy. Our data provide evidence that both antibiotic use and connectivity measurably influence hospital AMR. Finally, we provide a ranking of key antibiotics by their estimated population-level impact on AMR that might help inform antimicrobial stewardship strategies.

Indexed as

Drug Resistance, BacterialHospitalsAnti-Bacterial AgentsBacteriaBacterial InfectionsCross InfectionHumansPatient TransferSepsisAnti-Bacterial Agentsantibiotic stewardshipantimicrobial resistanceE. coliecologyEnterobacter cloacaeinfection controlinfectious diseaseKlebsiella pneumoniaemicrobiologyMRSA

Identifiers

PMID33106223
PMCPMC7690951
OpenAlexW3094325431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.